GZ
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
$2.34 +0.00% (+$0.00)
Market Cap ¥41.6B
P/E Ratio 16.31x
Div. Yield 3.78%
ROE 6.61%
Bulios Fair Price
$1.22
47.9% downside
Current Price
$2.34
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GZPHF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
64 /100
Fair EV/EBITDA 15.01x
P/S 0.54x
P/B 1.06x
Growth
22 /100
Declining Rev. growth 2.15%
Book val. growth 5.64%
EPS growth 9.31%
Profitability
21 /100
Weak Net margin 3.29%
Op. margin 3.67%
FCF margin 2.79%
Quality
31 /100
Poor ROE 6.61%
ROA 2.90%
Asset turnover 0.88x
Debt
63 /100
Moderate Current ratio 1.65x
Int. coverage 7.37x
Net debt/EBITDA 3.10x
Stability
72 /100
Stable Rev. volatility 3.93%
EPS volatility 19.35%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GZPHF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Hong Li
Employees
27,057
Headquarters
Guangzhou
Upcoming events
27 OCT
Earnings
Upcoming earnings report